trial
as of 2026-07-01Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients
NCTId NCT00255918
at a glance
Phase 1 · Completed
Enrollment 12 (actual)
Sponsored by University of Colorado, Denver
Primary completion 2005-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2004-03
Primary completion
2005-10
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
University of Colorado, DenverLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
Robert Freedman, MDPrincipal Investigator
Sites
1 total
Denver, United States
Facts & assertions
4 sourced
Enrollment
12
Phase
PHASE1
Primary Completion Date
2005-10
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
collaborator
indication
investigator
person